GGrantIndex
Sort

141,003 grants matching cytokine

Cellular and Developmental Biology of Coxiella burnetii

$1,168,921
Robert A Heinzen · National Institute Of Allergy And Infectious Diseases · ZIA · FY2010 · AI

TRAUMA PRIMES CELLS

$1,168,773
University Of Colorado Denver · P50 · FY2003 · GM

Transgenic Animal Models Of Human Immune Defects

$1,168,549
Steven Holland · National Institute Of Allergy And Infectious Diseases · ZIA · FY2018 · AI

Genes And Gene Products As Immunoadjuvants

$1,168,549
Steven Holland · National Institute Of Allergy And Infectious Diseases · ZIA · FY2018 · AI

Cancer Immunotherapy Clinical Trials

$1,168,320
Julius Strauss · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA

Role of Immune and Inflammation Mediators in Progression of Pancreatic Cancer

$1,168,220
Syed Perwez Hussain · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA

ANTI-OXIDANT THERAPY OF SMOKE INHALATION INJURY

$1,168,116
Inotek Pharmaceuticals Corporation · R44 · FY2000 · HL

GrowthDifferentiation Factors in Organogenesis

$1,168,017
Alan Perantoni · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA

Identifying Roadblocks to Antigen Expression and Enhancing Killing of HIV-Infected Cells That Are Refractory to Clearance

$1,167,948
Sarah Beth Joseph · Univ Of North Carolina Chapel Hill · R01 · FY2023 · AI

Identifying Roadblocks to Antigen Expression and Enhancing Killing of HIV-Infected Cells That Are Refractory to Clearance

$1,167,948
Sarah Beth Joseph · Univ Of North Carolina Chapel Hill · R01 · FY2024 · AI

Predictors of Pregnancy Outcome in SLE and APS

$1,167,785
Hospital For Special Surgery · R01 · FY2004 · AR

Dermatology Consultation Service

$1,167,752
Edward Cowen · Division Of Basic Sciences - Nci · ZID · FY2011 · CA

Autologous T Cell Therapy for CLL

$1,167,553
Xcyte Therapies, Inc. · R44 · FY2003 · CA

P01-Pathogenesis and Prevention of Osteoporosis

$1,167,331
University Of Connecticut Sch Of Med/Dnt · P01 · FY2001 · AR

Retroviral genetic modification of PBLs to optimize expansion for cell therapy

$1,166,802
Nicholas Klemen · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA

A Novel Systemic and Mucosal Adjuvant for Biodefense

$1,166,198
Robert E. Johnston · Global Vaccines, Inc. · U01 · FY2007 · AI

Determining the mechanism of IFIH1 disease-associated variants on beta-cell and immune responses in Type 1 diabetes

$1,166,173
Hubert M Tse · University Of Alabama At Birmingham · R01 · FY2021 · DK

Determining the mechanism of IFIH1 disease-associated variants on beta-cell and immune responses in Type 1 diabetes

$1,166,173
Hubert M Tse · University Of Alabama At Birmingham · R01 · FY2022 · DK

Programming T Cell Fates for Therapeutic Use

$1,166,116
Luca Gattinoni · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA

NADPH Oxidases as Novel Targets for Cancer Therapy

$1,166,042
James Doroshow · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA

Data and Analysis Core

$1,165,964
Matthew Douglas Johnson · University Of Minnesota · U54 · FY2023 · AT

Immunoregulation /Immune Recognition In Filarial/Nonfilarial Parasitic Infection

$1,165,642
Thomas Nutman · National Institute Of Allergy And Infectious Diseases · ZIA · FY2019 · AI

Gastointestinal Hormone Research Core Center

$1,165,502
Chung Owyang · University Of Michigan At Ann Arbor · P30 · FY2012 · DK

Gastointestinal Hormone Research Core Center

$1,165,490
Chung Owyang · University Of Michigan At Ann Arbor · P30 · FY2014 · DK

Gastointestinal Hormone Research Core Center

$1,165,490
Chung Owyang · University Of Michigan At Ann Arbor · P30 · FY2015 · DK